Eli Lilly releases new form of weight loss drug Zepbound for half the price to boost access, supply
Publishing timestamp: 2024-08-27 09:23:16
Summary
Eli Lilly released a new form of its weight loss drug Zepbound at a lower price to increase access for patients without insurance coverage. The move aims to expand the supply of Zepbound in the U.S. and ensure patients are safely accessing treatment as cheaper copycat versions of the drug gain traction.
Sentiment: NEUTRAL
Keywords: biotechnology, health care industry, united states, business, biotech and pharmaceuticals, eli lilly and co, novo nordisk a/s, business news, pharmaceuticals,